Monday, August 31, 2026 SourcesAbout🌓
🇺🇸 US ▾
BREAKING
Business

Lilly to buy Merida Biosciences for up to $2.88 billion in autoimmune drug push

CNBC ·

Eli ⁠Lilly ​plans to buy privately held ⁠Merida Biosciences for ‌up to $2.88 billion ​in cash.

Read the full article on CNBC ›

5News aggregated this summary from the outlet’s public feed. The full article, with all the context, is on www.cnbc.com — the content belongs to CNBC.

More from CNBC

See all ›

More in Business

See all ›